11/14/2024
3:56 PM | Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13G/A | |
10/22/2024
7:14 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:18 PM | Artiva Biotherapeutics (Issuer)
MOORE ALISON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:13 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:16 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:00 PM | Artiva Biotherapeutics (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13G | |
08/01/2024
3:17 PM | 5AM Ventures VI, L.P. (Filed by)
Artiva Biotherapeutics (Subject)
| Form SC 13G | |
|
08/01/2024
3:18 PM | Artiva Biotherapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
07/29/2024
3:29 PM | Artiva Biotherapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D | |
07/29/2024
3:15 PM | Artiva Biotherapeutics (Subject)
GC Corp. (Filed by)
| Form SC 13D | |
07/24/2024
3:27 PM | Artiva Biotherapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:15 PM | 5AM Opportunities II , LLC (0001873515) (Reporting)
5AM Opportunities II, L.P. (Reporting)
5AM Partners VI, LLC (Reporting)
5AM Ventures VI, L.P. (Reporting)
Artiva Biotherapeutics (Issuer)
PARMAR KUSH (Reporting)
Schwab Andrew J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:18 PM | Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:22 PM | Artiva Biotherapeutics (Issuer)
Huh Yong-Jun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:25 PM | Artiva Biotherapeutics (Issuer)
GC Cell Corp (Reporting)
GC Corp. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:26 PM | Adelman Robert J (Reporting)
Artiva Biotherapeutics (Issuer)
GOODMAN COREY S (Reporting)
venBio Global Strategic Fund III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:28 PM | Artiva Biotherapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
4:30 PM | Artiva Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/22/2024
3:19 PM | Artiva Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
11:15 PM | Artiva Biotherapeutics (Filer)
| Form EFFECT | |
07/18/2024
7:14 PM | Adelman Robert J (Reporting)
Artiva Biotherapeutics (Issuer)
GOODMAN COREY S (Reporting)
venBio Global Strategic Fund III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, L.P. (Reporting)
VENBIO GLOBAL STRATEGIC GP III, LTD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:00 PM | Artiva Biotherapeutics (Issuer)
Aslan Fred (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:00 PM | Artiva Biotherapeutics (Issuer)
Bush Jennifer (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:01 PM | Artiva Biotherapeutics (Issuer)
Horan Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:01 PM | Artiva Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:01 PM | Artiva Biotherapeutics (Issuer)
Graef Thorsten (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:02 PM | Artiva Biotherapeutics (Issuer)
Bessen Laura (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:02 PM | Artiva Biotherapeutics (Issuer)
Huh Yong-Jun (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:02 PM | Artiva Biotherapeutics (Issuer)
Raymon Heather (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:03 PM | Artiva Biotherapeutics (Issuer)
DANIELS BRIAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:04 PM | Artiva Biotherapeutics (Issuer)
HOUGEN ELIZABETH L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:05 PM | Artiva Biotherapeutics (Issuer)
GC Cell Corp (Reporting)
GC Corp. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:05 PM | Artiva Biotherapeutics (Issuer)
Stoppel Laura (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:06 PM | Artiva Biotherapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:06 PM | Artiva Biotherapeutics (Issuer)
Miralles Gines Diego (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:06 PM | 5AM Partners VI, LLC (Reporting)
5AM Ventures VI, L.P. (Reporting)
Artiva Biotherapeutics (Issuer)
PARMAR KUSH (Reporting)
Schwab Andrew J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
7:08 PM | Artiva Biotherapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
4:55 PM | Artiva Biotherapeutics (Filer)
| Form S-1MEF | |
07/15/2024
5:07 AM | Artiva Biotherapeutics (Filer)
| Form S-1/A | |
